Novel process and formulations

Details for Australian Patent Application No. 2006315162 (hide)

Owner Glaxo Group Limited

Inventors Taggart, John J.; Abu Khalil, As'ad; Lloyd, Richard S.; Diederich, Ann M.; Blatcher, Philip; Spoors, Paul G.; Appleby, John robert George; Vernon, Lois E.; Kasparec, Jiri; Humphries, Lesley Anne

Agent Davies Collison Cave

Pub. Number AU-A-2006315162

PCT Pub. Number WO2007/059500

Priority 60/736,679 15.11.05 US

Filing date 15 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059500 Priority application(s): WO2007/059500

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315163-Extracellular matrix components for expansion or differentiation of hepatic progenitors

2006315149-Rapid non-equilibrium decompression of microorganism-containing waste streams